ALK-Abello A/S

LSE:0OIR

ALK-Abello makes allergy treatment medicines and testing products. Its main business is allergy immunotherapy, which helps patients become less sensitive to things like pollen, dust mites, and animal allergens over time. It also sells allergy diagnostics used by doctors and clinics to identify what triggers a patient’s symptoms. The company sells through healthcare channels rather than directly to everyday shoppers. Its customers include doctors, allergy specialists, hospitals, clinics, pharmacies, and distributors in different countries. ALK-Abello earns money by selling prescription allergy tablets and drops, injection-based allergy treatments, and diagnostic products used in medical practice. What makes ALK-Abello different is that it sits in a narrow part of the drug market focused on the causes of allergies, not just symptom relief. Its products are used over long treatment periods and require medical guidance, which creates a specialized relationship with doctors and health systems. That makes the company more like a focused allergy platform than a broad drugmaker.